Salicylic Acid

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the removal of common and plantar warts. Common warts are characterized by their rough, 'cauliflower-like' surface appearance, while plantar warts are specifically located on the bottom of the foot, presenting tenderness and disrupting the normal footprint pattern.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The affected area should be washed thoroughly, and warts may be soaked in warm water for approximately 5 minutes to facilitate treatment. After soaking, the area must be dried completely. A small amount of the wart remover should then be applied using the provided applicator, ensuring that each wart is sufficiently covered.

This application should be allowed to dry, and the procedure may be repeated once or twice daily as necessary. Treatment can continue for up to 12 weeks, or until the wart is removed.

Contraindications

Use is contraindicated in the following situations:

Patients with diabetes or poor blood circulation should not use this product, except under the supervision of a healthcare professional, due to the increased risk of complications.

Application is not recommended on genital warts or warts located on the face, as well as on moles, birthmarks, and warts with hair growth, due to the potential for adverse effects.

The product should not be applied to mucous membranes or on skin that is irritated, infected, or reddened, as this may exacerbate the condition or lead to further complications.

Warnings and Precautions

For external use only. This product is flammable; therefore, it must be kept away from fire or flame. It is essential to cap the bottle tightly and store it at room temperature, away from heat sources.

This product should not be used by individuals who are diabetic or have poor blood circulation, unless under the supervision of a healthcare professional, such as a doctor or podiatrist. It is contraindicated for application on genital warts, warts on the face, moles, birthmarks, and warts with hair growing from them. Additionally, it should not be applied to mucous membranes or on skin that is irritated, infected, or reddened.

When using this product, it is crucial to avoid contact with the eyes. In the event that the product comes into contact with the eyes, it should be flushed with water for at least 15 minutes. Users should also take care to avoid inhaling vapors.

If discomfort persists, it is advised to discontinue use and consult a healthcare professional.

This product must be kept out of reach of children. In the case of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center should be made without delay.

Side Effects

Patients should be aware that this product is intended for external use only. It is contraindicated for individuals who are diabetic or have poor blood circulation, unless used under the supervision of a healthcare professional, such as a doctor or podiatrist. The product should not be applied to genital warts, warts on the face, moles, birthmarks, or warts with hair growing from them. Additionally, it should not be used on mucous membranes or on skin that is irritated, infected, or reddened.

During use, patients should take care to avoid contact with the eyes. In the event that the product comes into contact with the eyes, it is recommended to flush the eyes with water for 15 minutes. Patients should also avoid inhaling vapors associated with the product.

If discomfort persists after application, patients are advised to discontinue use and consult a healthcare professional. It is important to keep this product out of reach of children. In the case of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Salicylic Acid (liquid wart remover). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the local Poison Control Center should be contacted without delay.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Pregnant patients should be advised against the use of this product if they have diabetes or poor blood circulation, unless under the supervision of a healthcare professional. The product is intended for external use only and is flammable; therefore, it should be kept away from fire or flame.

During use, it is crucial to avoid contact with the eyes. In the event of contact, the affected area should be flushed with water for 15 minutes. Additionally, inhalation of vapors should be avoided. If discomfort persists, pregnant patients are advised to discontinue use and consult a healthcare provider.

As with all medications and topical products, this product should be kept out of reach of children. In cases of accidental ingestion, immediate medical assistance should be sought or contact with a Poison Control Center is recommended. The safety of this product during pregnancy has not been established, and caution is warranted.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or its effects on lactation. Additionally, no data are provided concerning the excretion of this medication in breast milk or its potential effects on breastfed infants. Healthcare professionals should consider the lack of information when advising lactating mothers about the use of this medication.

Renal Impairment

Patients with renal impairment may not have specific dosage adjustments, special monitoring, or safety considerations outlined in the drug insert. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment and monitoring of these patients.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical intervention is crucial. If the substance is ingested, it is imperative to seek medical assistance or contact a Poison Control Center without delay.

Healthcare professionals should be aware that prompt action can significantly influence the outcome of an overdosage situation. Symptoms of overdosage may vary depending on the specific substance involved; therefore, a thorough assessment of the patient's condition is essential.

Management procedures should include supportive care and symptomatic treatment as necessary. Continuous monitoring of the patient's vital signs and clinical status is recommended to ensure appropriate interventions are implemented in a timely manner.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental ingestion. In the event of swallowing the product, patients should seek medical help or contact a Poison Control Center immediately.

Patients should be informed that this product is not recommended for use in individuals with diabetes or poor blood circulation unless under the supervision of a healthcare professional, such as a doctor or podiatrist. Additionally, patients should be cautioned against using the product on genital warts, facial warts, moles, birthmarks, or warts with hair growing from them. It is also important to instruct patients not to apply the product on mucous membranes or on skin that is irritated, infected, or reddened.

Patients should be advised to discontinue use and consult a doctor if discomfort persists after application. Furthermore, when using this product, patients should be reminded to avoid contact with their eyes. In case the product comes into contact with the eyes, they should flush the eyes with water for at least 15 minutes. Lastly, patients should be warned to avoid inhaling vapors while using the product to ensure their safety.

Storage and Handling

The product is supplied in a tightly capped bottle, which must be stored at room temperature, specifically between 20°-25°C (68°-77°F). It is essential to keep the container away from heat sources and to ensure that it is closed tightly to prevent solidification. Additionally, the product should be kept away from fire or flame and stored in a cool place to maintain its integrity.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Salicylic Acid, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)